Skip to main content
Value8 N.V. logo

Value8 N.V. — Investor Relations & Filings

Ticker · VALUE ISIN · NL0010661864 LEI · 724500IOX980PF17L830 AS Financial and insurance activities
Filings indexed 504 across all filing types
Latest filing 2021-11-25 Earnings Release
Country NL Netherlands
Listing AS VALUE

About Value8 N.V.

https://www.value8.com/

Value8 N.V. is an investment company that focuses on acquiring and managing holdings in small and medium-sized companies. The firm specializes in various investment strategies, including middle-market buyouts, add-on acquisitions, and providing growth capital. Its primary objective is to achieve long-term value creation for its portfolio companies. Value8 maintains a diverse portfolio with investments in sectors such as healthcare services and equipment, IT business and cloud integration, and platforms for independent professionals.

Recent filings

Filing Released Lang Actions
Value8 doorbreekt grens 100 miljoen euro
Earnings Release Classification · 99% confidence The document is dated November 25, 2021, and provides an update on the company's performance for the third quarter (Q3) of 2021. It discusses the intrinsic value per share, portfolio value reaching 102.0 million euros, and provides detailed operational updates on key investments (Ctac, Renewi, Kersten, PIDZ). The language used ('trading update', 'Geachte aandeelhouder', discussion of quarterly results and portfolio movements) strongly suggests this is a periodic report summarizing financial performance for a period shorter than a year, but more detailed than a simple earnings release. This aligns best with the definition of an Interim / Quarterly Report (IR). It is not a full Annual Report (10-K), a simple Earnings Release (ER) which usually contains only key highlights, nor a Call Transcript (CT). Since it details performance over nine months/Q3, IR is the most appropriate classification. Q3 2021
2021-11-25 Dutch
Kwartaaldividend op de Cumprefs
Notice of Dividend Amount Classification · 98% confidence The document is a short press release ('PERSBERICHT') dated October 13, 2021, specifically announcing the dividend amount for cumulative preferred shares for the third quarter ('Kwartaaldividend op de Cumprefs'). It details the amount (€0.075 per share), the ex-dividend date, record date, and payment date. This content directly matches the definition for 'Notice of Dividend Amount' (DIV). It is too specific for a general Regulatory Filing (RNS) and is not a comprehensive report (like IR or 10-K).
2021-10-13 Dutch
Mededeling
Share Issue/Capital Change Classification · 99% confidence The document is a formal announcement dated October 6, 2021, detailing Almunda Professionals' intention to acquire a 60% stake in PIDZ, a healthcare staffing platform. It discusses the transaction details, financing (share issuance), and financial projections for PIDZ. Crucially, the text explicitly states: "Daartoe wordt een buitengewone algemene vergadering van aandeelhouders opgeroepen, die op 17 november a.s. zal plaatsvinden" (For this purpose, an extraordinary general meeting of shareholders is called, which will take place on November 17th). This indicates the document is related to calling a shareholder meeting to approve a major transaction. The final sentence refers to attachments for the 'oproeping voor de BAVA' (call for the EGM). This strongly suggests the document is either the official notice/proxy material for the meeting or an announcement leading up to it. Since it details the transaction requiring shareholder approval and calls the meeting, it relates directly to the process of soliciting shareholder votes and providing necessary information, fitting the description of Proxy Solicitation & Information Statement (PSI). Although it announces a transaction (M&A/TAR), the primary action described is calling the EGM for approval, making PSI or AGM-R more appropriate. Given the context of calling a meeting for approval, PSI is the best fit, as it precedes the actual meeting materials (AGM-R).
2021-10-07 Dutch
Mededeling
Regulatory Filings Classification · 95% confidence The document is a very short press release ("PERSBERICHT") dated October 7, 2021, announcing an agreement regarding the acquisition of a stake in PIDZ Holding by Almunda. Crucially, it explicitly states: "Voor meer informatie wordt verwezen naar het bijgevoegde persbericht van Almunda en de website www.almunda.nl" (For more information, please refer to the attached press release from Almunda and the website www.almunda.nl). This structure—a brief announcement directing the reader elsewhere for the full details—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since it is announcing a significant corporate action (M&A activity), but is itself just a notification pointing to another document, RPA is a strong candidate if the primary document being announced is a report. However, given the content is a direct announcement of a transaction (acquisition/disposal of a stake), it strongly relates to M&A Activity (TAR). Since the document itself is extremely short and merely points to an attached/external press release, it aligns best with the 'announcement of a report/event' category rather than the detailed report itself. Given the M&A context, and the short nature pointing to another document, RPA is appropriate as it is an announcement about the publication of the main news, or RNS as a general regulatory announcement. Given the specific nature of the event (acquisition/disposal), and the short length pointing to external info, I will classify it as a general Regulatory Filing (RNS) as it is a broad announcement, though TAR is the underlying event type. Given the 'MENU VS MEAL' rule, RPA is often used for announcing the release of a formal report. Since this is a press release announcing a transaction, RNS is the safest general regulatory fallback for a short announcement not fitting a specific report type.
2021-10-07 Dutch
Aandeelhoudersbrief: Value8 13 jaar
Management Reports Classification · 95% confidence The document is dated September 24, 2021, and is addressed to shareholders ('Geachte aandeelhouder, beste relatie'). It discusses the 13th anniversary of the investment company Value8, reviews past successes (investments in Ctac, Renewi, Kersten), highlights the growth in intrinsic value per share (from 41 eurocent to 8.55 euro), and mentions recent acquisitions (PIDZ). It also touches upon management continuity and ESG philosophy. This content strongly suggests a letter from management to shareholders summarizing performance over a period, likely accompanying or summarizing the half-year results mentioned ('Getuige onze halfjaarcijfers'). Since it is a detailed narrative review of performance, strategy, and outlook, it fits best under Management Reports (MDA) or potentially an Investor Presentation (IP) if it were structured as slides, but the narrative format points towards MDA. It is not a formal regulatory filing like a 10-K or IR, nor is it a short announcement (RPA/RNS). Given the detailed discussion of business trends and outlook following financial figures, MDA is the most appropriate classification.
2021-09-24 Dutch
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is a 'Halfjaarbericht 2021' (Half-year report 2021) for Value8 N.V. It contains comprehensive financial statements, including a balance sheet, income statement, cash flow statement, and detailed management commentary on business performance, investments, and outlook for the first half of the fiscal year. Since it covers a period shorter than a full fiscal year and includes substantive financial data and analysis, it is classified as an Interim/Quarterly Report. H1 2021
2021-07-26 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.